BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 18090583)

  • 1. Clinicopathological factors associated with unexpected N3 in patients with mediastinal lymph node involvement.
    Sakao Y; Miyamoto H; Oh S; Takahashi N; Sakuraba M
    J Thorac Oncol; 2007 Dec; 2(12):1107-11. PubMed ID: 18090583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The spread of metastatic lymph nodes to the mediastinum from left upper lobe cancer: results of superior mediastinal nodal dissection through a median sternotomy.
    Sakao Y; Miyamoto H; Yamazaki A; Ou S; Shiomi K; Sonobe S; Sakuraba M
    Eur J Cardiothorac Surg; 2006 Sep; 30(3):543-7. PubMed ID: 16870462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe.
    Sakao Y; Okumura S; Mingyon M; Uehara H; Ishikawa Y; Nakagawa K
    J Thorac Oncol; 2011 Mar; 6(3):494-9. PubMed ID: 21266920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognosis and prognostic factor after extended lymphadenectomy in lung cancer].
    Sakao Y; Hata E; Miyamoto H; Harada R; Hamada T
    Nihon Kyobu Geka Gakkai Zasshi; 1997 May; 45(5):711-7. PubMed ID: 9170862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
    Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
    Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
    Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
    Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved.
    Matsunaga T; Suzuki K; Takamochi K; Oh S
    Eur J Cardiothorac Surg; 2014 Jul; 46(1):86-91. PubMed ID: 24321998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2?
    Rea F; Marulli G; Callegaro D; Zuin A; Gobbi T; Loy M; Sartori F
    Lung Cancer; 2004 Aug; 45(2):215-20. PubMed ID: 15246193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer.
    Misthos P; Sepsas E; Kokotsakis J; Skottis I; Lioulias A
    Ann Thorac Surg; 2008 Nov; 86(5):1626-30. PubMed ID: 19049761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extent of removal for mediastinal nodal stations for patients with clinical stage I non-small cell lung cancer: effect on outcome.
    Jeon HW; Moon MH; Kim KS; Kim YD; Wang YP; Park HJ; Park JK
    Thorac Cardiovasc Surg; 2014 Oct; 62(7):599-604. PubMed ID: 24420680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is lobe-specific lymph node dissection appropriate in lung cancer patients undergoing routine mediastinoscopy?
    Turna A; Solak O; Kilicgun A; Metin M; Sayar A; Gürses A
    Thorac Cardiovasc Surg; 2007 Mar; 55(2):112-9. PubMed ID: 17377865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prognostic Significance of Metastasis to Lymph Nodes in Aortopulmonary Zone (Stations 5 and 6) in Completely Resected Left Upper Lobe Tumors.
    Citak N; Sayar A; Metin M; Büyükkale S; Kök A; Solak O; Yurt S; Gürses A
    Thorac Cardiovasc Surg; 2015 Oct; 63(7):568-76. PubMed ID: 25893919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediastinal nodal involvement in patients with clinical stage I non-small-cell lung cancer: possibility of rational lymph node dissection.
    Haruki T; Aokage K; Miyoshi T; Hishida T; Ishii G; Yoshida J; Tsuboi M; Nakamura H; Nagai K
    J Thorac Oncol; 2015 Jun; 10(6):930-6. PubMed ID: 26001143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The necessity of extended systemic dissection of the regional lymph node in radical operation for lung cancer].
    Hata E; Miyamoto H; Tanaka M; Sakao Y; Harada R; Kohiyama R
    Kyobu Geka; 1994 Jan; 47(1):40-4. PubMed ID: 8277632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Size of metastatic and nonmetastatic mediastinal lymph nodes in non-small cell lung cancer.
    Ikeda K; Nomori H; Mori T; Kobayashi H; Iwatani K; Yoshimoto K
    J Thorac Oncol; 2006 Nov; 1(9):949-52. PubMed ID: 17409977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Patterns of mediastinal and supraclavicular metastases in apical invasive lung cancer--importance of supraclavicular lymph node dissection].
    Niwa H; Yamakawa Y; Fuka I; Kiriyama M; Katayama Y; Tanamura O; Ninoyu K; Yokochi T; Masaoka A; Satake A
    Nihon Kyobu Geka Gakkai Zasshi; 1994 Aug; 42(8):1142-7. PubMed ID: 7963827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of predictive factors for postoperative survival for non small cell lung carcinoma patients with unexpected mediastinal lymph nodes metastasis.
    Wang S; Zhou W; Zhang H; Zhao M; Chen X
    Thorac Cardiovasc Surg; 2014 Mar; 62(2):126-32. PubMed ID: 23585223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skip mediastinal nodal metastases in the IIIa/N2 non-small cell lung cancer.
    Ilic N; Petricevic A; Arar D; Kotarac S; Banovic J; Ilic NF; Tripkovic A; Grandic L
    J Thorac Oncol; 2007 Nov; 2(11):1018-21. PubMed ID: 17975493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe.
    Inoue M; Sawabata N; Takeda S; Ohta M; Ohno Y; Maeda H
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1100-6. PubMed ID: 15052208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.